X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (66) 66
index medicus (62) 62
hematology (46) 46
oncology (37) 37
multiple myeloma - genetics (28) 28
multiple myeloma (26) 26
article (21) 21
mutation (21) 21
cancer (20) 20
female (20) 20
abridged index medicus (18) 18
male (17) 17
prognosis (17) 17
chromosome aberrations (16) 16
multiple myeloma - drug therapy (14) 14
mutations (14) 14
aged (13) 13
lymphoid neoplasia (13) 13
gene expression profiling (12) 12
multiple-myeloma (12) 12
comparative genomic hybridization (11) 11
expression (11) 11
gene expression regulation, neoplastic (11) 11
genetic aspects (11) 11
human necessities (11) 11
hygiene (11) 11
investigating or analysing materials by determining theirchemical or physical properties (11) 11
leukemia (11) 11
measuring (11) 11
medical or veterinary science (11) 11
middle aged (11) 11
physics (11) 11
preparations for medical, dental, or toilet purposes (11) 11
testing (11) 11
bortezomib (10) 10
nf-kappa-b (10) 10
survival (10) 10
acgh (9) 9
cell line, tumor (9) 9
chronic lymphocytic-leukemia (9) 9
genomics (9) 9
multiple myeloma - diagnosis (9) 9
specific therapeutic activity of chemical compounds ormedicinal preparations (9) 9
waldenstrom macroglobulinemia - genetics (9) 9
gene mutations (8) 8
identification (8) 8
multiple myeloma - metabolism (8) 8
risk (8) 8
translocation, genetic (8) 8
analysis (7) 7
cytogenetics (7) 7
disease progression (7) 7
gene expression (7) 7
genes (7) 7
genetics (7) 7
hematology, oncology and palliative medicine (7) 7
hemic and lymphatic diseases (7) 7
in-situ hybridization (7) 7
multiple myeloma - pathology (7) 7
signal transduction (7) 7
thalidomide - analogs & derivatives (7) 7
therapy (7) 7
adult (6) 6
animals (6) 6
antineoplastic agents - pharmacology (6) 6
gene deletion (6) 6
immune system diseases (6) 6
in situ hybridization, fluorescence (6) 6
lenalidomide (6) 6
leukemia, lymphocytic, chronic, b-cell - genetics (6) 6
medicine & public health (6) 6
mice (6) 6
abnormalities (5) 5
activation (5) 5
array-based comparative genomic hybridization (5) 5
biology (5) 5
biomarkers, tumor - genetics (5) 5
cll (5) 5
cohort studies (5) 5
dexamethasone (5) 5
dna (5) 5
drug resistance, neoplasm - genetics (5) 5
gene sequencing (5) 5
high-throughput nucleotide sequencing (5) 5
karyotyping (5) 5
lymphoma (5) 5
lymphomas (5) 5
monoclonal gammopathy (5) 5
nf-kappa b - metabolism (5) 5
p53 protein (5) 5
proteasome inhibitors (5) 5
thalidomide - pharmacology (5) 5
translocations (5) 5
tumor proteins (5) 5
102 (4) 4
aberrations (4) 4
acute lymphoblastic-leukemia (4) 4
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
apoptosis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Future Oncology, ISSN 1479-6694, 12/2013, Volume 9, Issue 12, pp. 1805 - 1808
Evaluation of: Avet-Loiseau H, Hulin C, Campion L et al. Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the... 
Journal Article
Future oncology (London, England), ISSN 1479-6694, 2013, Volume 9, Issue 12, pp. 1805 - 1808
Evaluation of: Avet-Loiseau H, Hulin C, Campion L et al. Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the... 
SURVIVAL | elderly patients | multiple myeloma | risk stratification | LENALIDOMIDE PLUS DEXAMETHASONE | BORTEZOMIB | CYTOGENETICS | INTERGROUPE FRANCOPHONE | THERAPY | ONCOLOGY | FISH | EXPERIENCE | EXPRESSION | GENETIC ABNORMALITIES
Journal Article
Future oncology (London, England), 12/2013, Volume 9, Issue 12, p. 1805
Chromosomal abnormalities are well-established biomarkers used in the subclassification and risk stratification of multiple myeloma patients. Patients with... 
Humans | Chromosome Aberrations | Multiple Myeloma - genetics
Journal Article
Cancer Research, ISSN 0008-5472, 2017, Volume 77, Issue 7, pp. 1510 - 1541
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13, pp. 3413 - 3420
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 10/2013, Volume 98, Issue 10, pp. 1586 - 1592
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2017, Volume 35, Issue 19, pp. 2217 - 2217
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 18, pp. 4771 - 4779
Journal Article
Cancer Treatment and Research, ISSN 0927-3042, 2016, Volume 169, pp. 321 - 361
Waldenström macroglobulinemia (WM) is a rare, indolent, and monoclonal immunoglobulin M-associated lymphoplasmacytic disorder with unique clinicopathologic... 
Waldenstrom’s macroglobulinemia | CXCR4 | BTK inhibitors | IgM | MYD88 | Waldenstrom Macroglobulinemia - therapy | Humans | Waldenstrom Macroglobulinemia - genetics | Chromosome Aberrations
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 5, pp. 432 - 443
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e43192
Pancreatic adenocarcinoma (PAC) is among the most lethal malignancies. While research has implicated multiple genes in disease pathogenesis, identification of... 
CANCER-CELLS | GROWTH-FACTOR RECEPTOR | K-RAS MUTATIONS | ACTIVATED RECEPTOR-GAMMA | MESSENGER-RNA EXPRESSION | COPY-NUMBER | MULTIDISCIPLINARY SCIENCES | TUMOR-SUPPRESSOR GENE | FREQUENT SOMATIC MUTATIONS | OF-FUNCTION MUTATIONS | PROGNOSTIC-SIGNIFICANCE | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Transcriptome | Male | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Gene Dosage | DNA Repair - genetics | Tumor Suppressor Protein p53 - genetics | Metabolic Networks and Pathways - genetics | Sequence Analysis, RNA | Base Sequence | Female | Adenocarcinoma - genetics | High-Throughput Nucleotide Sequencing | Proto-Oncogene Proteins c-myc - genetics | Genome, Human | BRCA2 Protein - genetics | Adenocarcinoma | RNA sequencing | Medical research | RNA | Genes | Genomics | Genomes | Gene mutations | Analysis | Pancreatic cancer | Medicine, Experimental | Genetic aspects | Nucleotide sequencing | Health aspects | DNA sequencing | Cancer | Target recognition | Copy number | Pathogenesis | Clinical trials | Identification | Metastasis | Kinases | Cancer therapies | K-Ras protein | Gene sequencing | Proteins | Signal transduction | Tumorigenesis | Pancreas | Deoxyribonucleic acid--DNA | Translocation | Stroma | Cell division | Gene expression | Ribonucleic acid--RNA | Patients | Signaling | Chemotherapy | Medical prognosis | Mutation | Aberration | Evolution & development | Tumors | Apoptosis | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66982
Glucocorticoid-induced TNF receptor (GITR) plays a crucial role in modulating immune response and inflammation, however the role of GITR in human cancers is... 
ACTIVATION | NK CELLS | PATHWAY | MULTIDISCIPLINARY SCIENCES | BIOLOGY | SUPERFAMILY | NEUROBLASTOMA | LIGAND | NF-KAPPA-B | CANCER | T-CELLS | Cell Proliferation | Prognosis | Multiple Myeloma - mortality | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Gene Expression Regulation, Neoplastic | NF-kappa B - metabolism | DNA Methylation | Tumor Suppressor Proteins - genetics | Apoptosis Regulatory Proteins - genetics | Proto-Oncogene Proteins p21(ras) - metabolism | Proto-Oncogene Proteins - metabolism | Promoter Regions, Genetic | Tumor Suppressor Proteins - metabolism | Signal Transduction | Glucocorticoid-Induced TNFR-Related Protein - metabolism | Glucocorticoid-Induced TNFR-Related Protein - genetics | Proto-Oncogene Proteins - genetics | Multiple Myeloma - metabolism | Disease Progression | Apoptosis Regulatory Proteins - metabolism | Animals | Models, Biological | Cell Line, Tumor | CpG Islands | Mice | Multiple Myeloma - genetics | Corticosteroids | Tumor necrosis factor | Genes | Multiple myeloma | Genetic engineering | Inflammation | Tumor proteins | Methylation | Tumors | Apoptosis | Steroids | Cell proliferation | Tumor necrosis factor receptors | Glucocorticoids | Pathogenesis | p53 Protein | Leukemia | Oncology | Medical schools | Restoration | DNA methylation | Tumor necrosis factor-TNF | Chromosomes | Deoxyribonucleic acid--DNA | CpG islands | Immune system | NF-κB protein | Antigens | Cell survival | Immune response | Gene expression | Gene silencing | Cell lines | Epigenetics | Plasma cells | Tumor suppressor genes | Ligands | Mutation | Cancer | Deoxyribonucleic acid | DNA
Journal Article